140 related articles for article (PubMed ID: 11402944)
1. [Implantable defibrillators. Sudden death: high risk].
Lellouche D; Pujadas-Berthault P; Elbaz N
Presse Med; 2001 May 5-12; 30(17):867-70. PubMed ID: 11402944
[TBL] [Abstract][Full Text] [Related]
2. [Implantable defibrillators. Role of the defibrillator in treatment and prevention of sudden death].
Lellouche D; Pujadas-Berthault P; Elbaz N
Presse Med; 2001 May 5-12; 30(17):871-3. PubMed ID: 11402945
[TBL] [Abstract][Full Text] [Related]
3. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
4. [Sudden cardiac death: who benefits from an implantable defibrillator?].
Sticherling C
Praxis (Bern 1994); 2005 May; 94(21):869-73. PubMed ID: 15966486
[No Abstract] [Full Text] [Related]
5. The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death.
Talajic M; Mitchell LB; Hadjis T
Can J Cardiol; 2000 Jun; 16 Suppl C():26C-8C. PubMed ID: 10887275
[No Abstract] [Full Text] [Related]
6. What can we expect from prophylactic implantable defibrillators?
Wilber DJ; Kall JG; Kopp DE
Am J Cardiol; 1997 Sep; 80(5B):20F-27F. PubMed ID: 9291446
[TBL] [Abstract][Full Text] [Related]
7. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
8. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
Finch NJ; Leman RB
Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
[TBL] [Abstract][Full Text] [Related]
10. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
Ferrari R; Cinca J; Marber M
Eur Heart J; 1999 Mar; 20(6):397-8. PubMed ID: 10213339
[No Abstract] [Full Text] [Related]
11. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study.
Kiès P; Boersma E; Bax JJ; van der Burg AE; Bootsma M; van Erven L; van der Wall EE; Schalij MJ
J Cardiovasc Electrophysiol; 2005 Oct; 16(10):1049-56. PubMed ID: 16191114
[TBL] [Abstract][Full Text] [Related]
12. Ventricular arrhythmias. Preventing sudden death with drugs and ICD devices.
Doherty JU; Fuchs S; Tecce MA
Geriatrics; 2000 Aug; 55(8):26-8, 31-2, 35-6. PubMed ID: 10953684
[TBL] [Abstract][Full Text] [Related]
13. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
[TBL] [Abstract][Full Text] [Related]
15. [Nursing care for automatic implantable defibrillators].
Pépin A; Samuel B; Kihel A
Soins; 2006; (702 Suppl):S3-5. PubMed ID: 16493932
[No Abstract] [Full Text] [Related]
16. Sudden cardiac death in dilated cardiomyopathy -- therapeutic options.
Grimm W; Maisch B
Herz; 2002 Dec; 27(8):750-9. PubMed ID: 12574892
[TBL] [Abstract][Full Text] [Related]
17. Use and long-term outcomes of implantable cardioverter-defibrillators, 1990 to 2009.
Bradshaw PJ; Stobie P; Briffa T; Hobbs MS
Am Heart J; 2013 May; 165(5):816-22. PubMed ID: 23622920
[TBL] [Abstract][Full Text] [Related]
18. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe?
Santangeli P; Dello Russo A; Casella M; Pelargonio G; Di Biase L; Natale A
Intern Med J; 2011 Jan; 41(1a):55-60. PubMed ID: 21265961
[TBL] [Abstract][Full Text] [Related]
20. [Implantable defibrillators--current status of guidelines. Recognized and possible indications--prerequisites].
Andresen D
Fortschr Med; 1996 Apr; 114(11):128-32. PubMed ID: 8682425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
